Despite the fact that estrogen metabolite 2-ME is a known anti-HCC agent and that CYP1A2, CYP3A4 and COMT are the key enzymes responsible for the production of 2-ME, little is known about their E2 metabolism in HCC. This evidence concerns the gene CYP1A2 and hepatocellular carcinoma.